Unknown

Dataset Information

0

KCa2 and KCa3.1 Channels in the Airways: A New Therapeutic Target.

ABSTRACT: K+ channels are involved in many critical functions in lung physiology. Recently, the family of Ca2+-activated K+ channels (KCa) has received more attention, and a massive amount of effort has been devoted to developing selective medications targeting these channels. Within the family of KCa channels, three small-conductance Ca2+-activated K+ (KCa2) channel subtypes, together with the intermediate-conductance KCa3.1 channel, are voltage-independent K+ channels, and they mediate Ca2+-induced membrane hyperpolarization. Many KCa2 channel members are involved in crucial roles in physiological and pathological systems throughout the body. In this article, different subtypes of KCa2 and KCa3.1 channels and their functions in respiratory diseases are discussed. Additionally, the pharmacology of the KCa2 and KCa3.1 channels and the link between these channels and respiratory ciliary regulations will be explained in more detail. In the future, specific modulators for small or intermediate Ca2+-activated K+ channels may offer a unique therapeutic opportunity to treat muco-obstructive lung diseases.

SUBMITTER: Orfali R 

PROVIDER: S-EPMC10376499 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

K<sub>Ca</sub>2 and K<sub>Ca</sub>3.1 Channels in the Airways: A New Therapeutic Target.

Orfali Razan R   AlFaiz Ali A   Rahman Mohammad Asikur MA   Lau Liz L   Nam Young-Woo YW   Zhang Miao M  

Biomedicines 20230621 7

K<sup>+</sup> channels are involved in many critical functions in lung physiology. Recently, the family of Ca<sup>2+</sup>-activated K<sup>+</sup> channels (K<sub>Ca</sub>) has received more attention, and a massive amount of effort has been devoted to developing selective medications targeting these channels. Within the family of K<sub>Ca</sub> channels, three small-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> (K<sub>Ca</sub>2) channel subtypes, together with the intermediate-conductance  ...[more]

Similar Datasets

Unknown Regulation of Ca v 3.1 channels by glucocorticoids.
| S-EPMC11505831 | biostudies-literature
Unknown Exenatide Inhibits the K<sub>Ca</sub>3.1 Channels of Aortic Vascular Smooth Muscle in Diabetic Rats.
| S-EPMC5694930 | biostudies-literature
Unknown Enhanced expression of β cell Ca<sub>V</sub>3.1 channels impairs insulin release and glucose homeostasis.
| S-EPMC6955371 | biostudies-literature
Unknown Imaging of K<sub>Ca</sub> 3.1 Channels in Tumor Cells with PET and Small-Molecule Fluorescent Probes.
| S-EPMC10098740 | biostudies-literature
Unknown Targeting K<sub>Ca</sub>3.1 channels to overcome erlotinib resistance in non-small cell lung cancer cells.
| S-EPMC10767088 | biostudies-literature
Unknown Muscle Damage in Dystrophic mdx Mice Is Influenced by the Activity of Ca<sup>2+</sup>-Activated K<sub>Ca</sub>3.1 Channels.
| S-EPMC9025295 | biostudies-literature
Unknown Synthesis and biological evaluation of PET tracers designed for imaging of calcium activated potassium channel 3.1 (K<sub>Ca</sub>3.1) channels <i>in vivo</i>.
| S-EPMC9041111 | biostudies-literature
Unknown Genetic deficit of K<sub>Ca</sub> 3.1 channels protects against pulmonary circulatory collapse induced by TRPV4 channel activation.
| S-EPMC4562510 | biostudies-literature
Unknown The feeding behaviour of Amyotrophic Lateral Sclerosis mouse models is modulated by the Ca<sup>2+</sup> -activated K<sub>Ca</sub> 3.1 channels.
| S-EPMC9293222 | biostudies-literature
Unknown Sub-synaptic localization of Ca<sub>v</sub>3.1 T-type calcium channels in the thalamus of normal and parkinsonian monkeys.
| S-EPMC5135628 | biostudies-literature